MYDX INC COM USD0.001 (MYDX)

0.0048 +0.0000 ( +0.0000% ) 17

Instant Analysis On Any Stock…

Your Marijuana Trend Report Is Ready!

 

Instant Analysis On Any Stock…

Your Marijuana Trend Report Is Ready!

 

MYDX Detailed Quote

Last Trade:   0.0048
Trade Time:   3:59pm
Change:   +0.0000
Perc Change:   +0.0000%
Prev Close:   0.0048
Open:   0.0048
Day's Range:   0.0043 - 0.0051
Bid:   N/A
EPS   -0.0600
52wk Range:   0.0010 - 0.1190
Volume:   6427509
Avg Vol:   13056400
Market Cap:   7.42M
P/E (ttm):   N/A
PES (ttm):   -0.0600
Ask:   N/A

MYDX Recent Headlines

  • MyDx Files Complaint Against Former Chief Operating Officer, Protects Unique AeroDx Diagnostic Platform and Addresses Toxic Financier's Unauthorized Conversion 07/18/2017 01:00 PMSAN DIEGO, July 18, 2017 /PRNewswire/ -- MyDx, Inc. (MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer initially designed for cannabis professionals and retail consumers to measure the chemicals in cannabis and track their feedback on how each sample is impacting their physiology, today announced that all previously reported variable toxic debts have been satisfied through the unauthorized conversion of the Crown Bridge note and has also filed a lawsuit against its former COO and other defendants who have attempted to create a competitive advantage with its anticipated product launch of its air quality sensor: AeroDx®. On July 14, 2017, the Company and its Chief Executive Officer, Daniel Yazbeck, filed a complaint in Superior Court of California against a series of Defendants who have allegedly engaged in unfair business practices, made false statements about the Company, its products, and Mr. Yazbeck at investor events and on online investor platforms.  There can be no assurance about the results or on the outcome of the lawsuit, however, the company took aggressive steps it felt were necessary to protect its business and its shareholders.
  • MyDx Supports Product Sales and Toronto's Gay Pride Parade Through Canadian Radio, Taxi Cab Advertisements and Billboards 06/29/2017 01:00 PMCompany Receives Initial Product Sales from its Canadian Campaign as it Ramps Up Over the Coming Month SAN DIEGO , June 29, 2017 /PRNewswire/ --  MyDx, Inc. (OTCQB:MYDX), a science and technology company ...
  • MyDx Enters Into An ~$80,000 MyDx360 SaaS Licensing And Services Agreement With Retailer BlackSwan 06/19/2017 01:00 PMSAN DIEGO, June 19, 2017 /PRNewswire/ -- MyDx, Inc. (MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for cannabis professionals and retail consumers to correlate the chemical profile of cannabis with how it makes them feel and which ailments they report it alleviates, today announced a definitive agreement with BlackSwan, a developer and retailer of custom vaporizers, to provide a community engagement software platform to support its new product development initiatives under the terms of MyDx360. As part of the MyDx360 agreement, BlackSwan chose from one of MyDx's base chemical formulations that best alleviated pain and inflammation according to the MyDx community. From there, MyDx software enabled BlackSwan to "boost" that formula by changing various cannabinoid and terpene parameters as well as other natural organic terpenes to come to a final formula uniquely formulated by BlackSwan.
  • MyDx Launches Canadian National Marketing Campaign to Promote Transparency and Prevent Abuse with Its CannaDx Cannabis Handheld Chemical Analyzer 06/15/2017 07:10 PMMulti Six Figure Campaign to Leverage Premium Television, Radio, Billboard and Print Media Across Canada SAN DIEGO, CA / ACCESSWIRE / June 15, 2017 / MyDx, Inc. (OTCQB: MYDX), a science and technology ...
  • MyDx Announces Successful Quality Control & Assurance Screening of its new MyDx 2.0 Units 05/31/2017 01:15 PMSAN DIEGO, May 31, 2017 /PRNewswire/ -- MyDx, Inc. (MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer designed for the Cannabis professional and retail consumer to correlate the chemical profile of cannabis with its therapeutic effect, today announces that the first batch from its 1,000 units of MyDx 2.0 were successfully assembled and passed a rigorous QA/QC screening process in its Silicon Valley manufacturing facility. With a host of new features and upgrades, MyDx 2.0 is comprised of over 200 individual components, backed by over 50 patents, that are meticulously pieced together with the highest standards of quality in mind. To support the sales of its new product, MyDx intends to implement a new marketing campaign to maximize brand exposure and communicate MyDx's value proposition to the masses.

FIND OUT HOW MUCH MOMENTUM IS DRIVING YOUR MARIJUANA STOCK!

AS SEEN ON
>>